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1. Introduction 
Cardiac catheterization was primarily a diagnostic procedure that was used to evaluate 
hemodynamics, ventricular function, and coronary anatomy. However, the introduction of 
improved angioplasty equipment and new interventional devices in the 1980s made 
catheterization an important tool in the treatment of cardiovascular disease. 
Although diagnostic catheterization and percutaneous coronary intervention are done by 
skin puncture rather than incision, and under local rather than general anesthesia, they can 
cause a variety of adverse events, ranging from minor problems without long-term sequelae 
to major complications requiring immediate corrective action. Furthermore, newer 
interventional procedures may be associated with different and, in some cases, more 
frequent complications. 
2. Major complications 
The risk of producing a major complication (death, myocardial infarction, or major 
embolization) during diagnostic cardiac catheterization is generally well below 1 percent. As 
a result, the risk-to-benefit ratio still favors performing this procedure as a part of the 
evaluation of potentially fatal or lifestyle limiting cardiac disease. 
The risk of an adverse event, for the individual patient, is dependent upon demographics, 
cardiovascular anatomy, clinical circumstances including comorbidities, the experience of 
the operator, and the type of procedure being performed (table 1 A-C) [1]. Severe peripheral 
artery disease is a risk factor for all of the major complications. 
2.1 Death  
Death following diagnostic cardiac catheterization is now rare. Compared with the 1 percent 
mortality rate seen in the 1960s, the second registry of the Society for Cardiac Angiography 
revealed that the procedural mortality had fallen to 0.1 percent in the more than 200,000 
patients catheterized between 1984 and 1987 [2]. 
High-risk subgroups have been identified in multiple large series [1-9]: 
www.intechopen.com
 
Advances in the Diagnosis of Coronary Atherosclerosis 
 
150 
  Percent 
Mortality 0.11 
Myocardial infarction 0.05 
Cerebrovascular accident 0.07 
Arrhythmia 0.38 
Vascular complications 0.43 
Contrast reaction 0.37 
Hemodynamic complications 0.26 
Perforation of heart chamber 0.28 
Other complications 0.28 
Total of major complications 1.70 
Noto, TJ Jr, Johnson, LW, Krone, R, et al. Cardiac catheterization 1990: A report of the Registry of the 
Society for Cardiac Angiography and Interventions (SCA&I). Cathet Cardiovasc Diagn 1991; 24:75.  
Table 1. (A): Risk of cardiac catheterization and coronary angiography (based on 59,792 
patients) 
 
Variable Odds ratio 
Moribund 10.22 
Shock 6.52 
Acute MI <24 h 4.03 
Renal insufficiency 3.30 
Cardiomyopathy 3.29 
Aortic valve disease 2.72 
Mitral valve disease 2.33 
Heart failure 2.33 
New York Heart Association Functional 
   Class I 1.00 
   Class II 1.15 
   Class III 1.32 
   Class IV  1.52 
Hypertension 1.45 
Unstable angina 1.42 
Outpatient/inpatient 0.63 
Moribund indicates a patient who responds poorly due to a life threatening condition.  
MI: myocardial infarction. 
Scanlon, PJ, Faxon, DP, Audet, AM, et al, J Am Coll Cardiol 1999; 33:1756. 
Table 1. (B): Multivariate predictors of major complications of coronary angiography (based 
on 58,332 procedures) 
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Acute renal failure 
Chronic renal failure secondary to diabetes 
Active gastrointestinal bleeding 
Unexplained fever, which may be due to infection 
Untreated active infection 
Acute stroke 
Severe anemia 
Severe uncontrolled hypertension 
Severe symptomatic electrolyte imbalance 
Severe lack of cooperation by patient due to psychological or severe systemic illness 
Severe concomitant illness that drastically shortens life expectancy or increases risk of 
therapeutic interventions 
Refusal of patient to consider definitive therapy such as PTCA, CABG, or valve 
replacement 
Digitalis intoxication 
Documented anaphylactoid reaction to angiographic contrast media 
Severe peripheral vascular disease limiting vascular access 
Decompensated heart failure or acute pulmonary edema   
Severe coagulopathy 
Aortic valve endocarditis 
PTCA: percutaneoas transluminal coronary angioplasty; CABG: coronary artety bypass graft.  
Scanlon, PJ, Faxon, DP, Audet, AM, et al, J Am Coll Cardiol 1999; 33:1756. 
Table 1. (C): Relative contraindications to coronary angiography 
 Patients with valvular heart disease, chronic kidney disease, diabetes mellitus requiring 
insulin therapy, peripheral artery disease, cerebrovascular disease, and pulmonary 
insufficiency all appear to have an increased incidence of death and major 
complications from cardiac catheterization. Mortality is especially high in those with 
preexisting renal insufficiency who have further deterioration of renal function within 
48 hours after the procedure, particularly when dialysis is required [10]. 
 A similar increase in risk is seen with severe disease of the left main coronary artery 
(compared to single vessel disease) and with a left ventricular ejection fraction (LVEF) 
below 30 percent (compared to an LVEF above 50 percent). 
 Age above 60 years and below one year and women have an increased mortality rate 
after catheterization. 
 New York Heart Association functional class IV is associated with an almost tenfold 
increase in mortality compared with classes I and II (table 2). 
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New York Heart 
Association functional 
classification
Canadian Cardiovascular Society 
functional classification 
Specific activity scale 
I 
Patients with cardiac 
disease but without 
resulting limitations of 
physical activity. Ordinary 
physical activity does not 
cause undue fatigue, 
palpitation, dyspnea, or 
anginal pain. 
Ordinary physical activity, such 
as walking and climbing stairs, 
does not cause angina. Angina 
with strenuous or rapid 
prolonged exertion at work or 
recreation. 
Patients can perform to 
completion any activity 
requiring ≥7 metabolic 
equivalents, eg, can carry 
24 lb up eight steps; do 
outdoor work (shovel 
snow, spade soil); do 
recreational activities 
(skiing, basketball, squash, 
handball, jog/walk 5 mph). 
II 
Patients with cardiac 
disease resulting in slight 
limitation of physical 
activity. They are 
comfortable at rest. 
Ordinary physical activity 
results in fatigue, 
palpitation, dyspnea, or 
anginal pain. 
Slight limitation of ordinary 
activity. Walking or climbing 
stairs rapidly, walking uphill, 
walking or stair climbing after 
meals, in cold, in wind, or when 
under emotional stress, or only 
during the few hours after 
awakening. Walking more than 
two blocks on the level and 
climbing more than one flight of 
ordinary stairs at a normal pace 
and in normal conditions. 
Patients can perform to 
completion any activity 
requiring ≤ 5 metabolic 
equivalents, eg, have 
sexual intercourse without 
stopping, garden, rake, 
weed, roller skate, dance 
fox trot, walk at 4 mph on 
level ground, but cannot 
and do not perform to 
completion activities 
requiring ≥ 7 metabolic 
equivalents. 
III 
Patients with cardiac 
disease resulting in 
marked limitation of 
physical activity. They are 
comfortable at rest. Less 
than ordinary physical 
activity causes fatigue, 
palpitation, dyspnea, or 
anginal pain. 
Marked limitation of ordinary 
physical activity. Walking one to 
two blocks on the level and 
climbing more than one flight in 
normal conditions. 
Patients can perform to 
completion any activity 
requiring ≤ 2 metabolic 
equivalents, eg, shower 
without stopping, strip and 
make bed, clean windows, 
walk 2.5 mph, bowl, play 
golf, dress without 
stopping, but cannot and 
do not perform to 
completion any activities 
requiring > 5 metabolic 
equivalents. 
IV 
Patient with cardiac 
disease resulting in 
inability to carry on any 
physical activity without 
discomfort. Symptoms of 
cardiac insufficiency or of 
the anginal syndrome may 
be present even at rest. If 
any physical activity is 
undertaken, discomfort is 
increased.
Inability to carry on any physical 
activity without discomfort - 
anginal syndrome may be present 
at rest. 
Patients cannot or do not 
perform to completion 
activities requiring > 2 
metabolic equivalents. 
Cannot carry out activities 
listed above (Specific 
activity scale III). 
Table 2. Comparison of three methods of assessing cardiovascular disability 
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2.2 Myocardial infarction 
Although periprocedural myocardial ischemia is fairly common, infarction is rare. The 
general risk of myocardial infarction (MI) in most series is less than 0.1 percent [2-7]. 
However, the risk of precipitating an MI in an individual patient is influenced by patient-
related and technique-related factors. Risk factors that predispose patients to MI during the 
procedure include:  
 Recent non-ST elevation acute coronary syndrome. 
 Extension of disease (0.17 percent with left main coronary disease versus 0.06 percent in 
single vessel disease) [2]. 
 Diabetes mellitus requiring insulin therapy [1]. 
2.3 Stroke and transient ischemic attack  
A stroke is a rare but potentially devastating complication of cardiac catheterization. The 
incidence of stroke was 0.07 to 0.10 percent in an analysis of two large databases [2,11] and 
has more recently been reported to be as high as 0.2 to 0.4 percent [12]. Risk factors for 
stroke include the severity of coronary artery disease, the length of fluoroscopy time, 
diabetes, hypertension, prior stroke, or renal failure [11,12]   
Stroke and transient ischemic attacks are thought to be caused by disruption of 
atheromatous plaques on the walls of the aorta. The risk of intracerebral hemorrhage is 
increased in those receiving anticoagulation or thrombolytic therapy as well as with any  of 
the following: age ≥75 years; female sex; systolic blood pressure ≥160 mmHg; black race; and 
low body weight (table 3). Based on the number of the risk factors present, the rate of 
intracerebral hemorrhage varies from less than 1 percent to more than 4 percent.  
 
Risk Factors* 
Age ≥75 years 
Black race 
Female sex 
Prior history of stroke
Systolic blood pressure ≥160 mmHg
Weight ≤65 kg for women or ≤80 kg for men
INR >4 or PT >24
Use of alteplase (versus other thrombolytic agent)
Risk score Rate of intracranial hemorrhage, percent





* Each risk factor is worth 1 point if present, 0 points if absent. Points are added to determine the risk 
score. 
 INR: international normalized ratio; PT: prothrombin time. 
Brass, LM, Lichtman, JH, Wang, Y, et al. Intracranial hemorrhage associated with thrombolytic therapy 
for elderly patients with acute myocardial infarction: results from the cooperative cardiovascular 
project. Stroke 2000; 31:1802. 
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Meticulous attention to technical factors such as wire and catheter exchanges is mandatory 
in all patients, regardless of risk. Transient neurologic deficits may also result from the 
injection of high osmolar contrast agents into the carotid or vertebral arteries. The majority 
of patients with a periprocedural stroke have an unfavorable neurologic outcome and, in 
one study, the in-hospital mortality was 32 percent [11]. 
2.4 Role of valvular aortic stenosis 
The risk of stroke may be particularly high in patients with valvular aortic stenosis (AS) who 
undergo retrograde catheterization of the aortic valve [13,14]. This was demonstrated in a 
study of 152 patients with severe AS (mean age 71 years) who were randomly assigned to 
cardiac catheterization with or without catheter passage through the valve [13]. The 
following findings were noted:  
 Detailed neurologic examination done before and after the catheterization 
demonstrated clinically apparent deficits in 3 percent of those who underwent 
retrograde catheterization, but in none of the other patients.  
 Cranial MRI done before and after the catheterization demonstrated focal lesions 
consistent with cerebral emboli in 22 percent of those who underwent retrograde 
catheterization of the aortic valve, but in none of the patients who did not. 
As a result, retrograde catheterization should be performed with caution in patients with 
severe calcific AS and only when the information sought cannot be reliably obtained 
noninvasively [14]. 
2.5 Asymptomatic embolic events  
The incidence of stroke after cardiac catheterization was 0.07 to 0.10 percent in an analysis of 
two large databases [2,11]. However, asymptomatic embolic events are much more common 
[13,15,16].  
This was illustrated in a prospective study of 48 patients (mean age 62 years) who 
underwent cardiac catheterization and angiography and, in some patients, percutaneous 
coronary intervention; magnetic resonance imaging (MRI) was performed before and about 
24 hours after the procedure [15]. There were no embolic lesions on diffusionweighted 
imaging at baseline, but seven patients (15 percent) had nine cerebral infarcts after the 
procedure; all were asymptomatic. 
Similar findings were noted in a report of 47 unselected patients in whom transcranial 
Doppler was used to detect microemboli and MRI to detect new lesions [16]. The median 
number of solid (ie, not gaseous) microemboli was significantly higher with a transradial 
compared to a transfemoral access (57 versus 36). New MRI lesions occurred in 5 of 33 
patients (15 percent) after transradial catheterization, compared to none of nine after 
transfemoral catheterization. Most of the patients with new lesions remained asymptomatic.  
These observations suggest that catheter manipulation in the diseased aortic root releases 
small pieces of atherosclerotic debris more commonly than suspected, based upon the 
fortunately low incidence of clinically apparent stroke. The same principles presumably 
apply to peripheral embolism. 
3. Local vascular complications 
Local complications at the site of catheter insertion are among the most common problems 
seen after cardiac catheterization. 
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These problems may include acute thrombosis, distal embolization, dissection or poorly 
controlled bleeding (which may be manifested as free hemorrhage or contained hematoma 
in the femoral or retroperitoneal areas), pseudoaneurysm, or arteriovenous fistula. 
Hemorrhage and hematoma are usually evident within 12 hours after the procedure by 
virtue of local discomfort, hypotension, or falling hematocrit, which lead to confirmatory 
noninvasive testing (ultrasound or CT). In contrast, other complications such as 
pseudoaneurysm and arteriovenous fistula may not become apparent for days to weeks 
afterward. 
3.1 Hemostasis at the access site 
The traditional approach to catheter removal at the conclusion of cardiac catheterization       
was local hand-applied pressure for 15 to 30 minutes.  
Two alternative approaches are available: mechanical clamp compression and more 
importantly, arterial puncture closing devices: 
3.1.1 Mechanical clamp 
Mechanical clamp compression reduces the amount of staff time and effort required to 
assure hemostasis, and may reduce the rate of vascular complications. One trial randomly 
assigned 778 patients to hand applied pressure or mechanical clamp pressure; the latter 
reduced the frequency of ultrasound-defined femoral vascular complications (femoral artery 
thrombosis, echogenic hematoma, pseudoaneurysm, or arteriovenous fistulae formation) by 
63 percent [17]. However, clamping does not decrease the importance of having staff in 
attendance to ensure that the device is placed and remains in the correct position. 
The circumstances which may make mechanical clamps the preferred method of achieving 
hemostasis include procedures where longer hemostasis time is anticipated: larger sheaths, 
excessively anticoagulated patients, recognized hematoma, and dual antiplatelet therapy 
3.1.2 Closure devices  
Arterial puncture closing devices (APCDs) eliminate the need for prolonged arterial 
compression and reduce the subsequent interval of bed rest that is otherwise required. Two 
types of APCDs in clinical use include collagen hemostatic puncture closure devices [18-21] 
and suture-mediated devices [22]. 
APCDs may increase the risk of local vascular complications. In a meta-analysis of 30 trials 
including 4000 patients who underwent coronary angiography or PCI, nonsignificant 
increases in the incidence of groin hematoma, bleeding, and pseudoaneurysm formation 
were associated with use of these devices compared to manual compression [23]. When only 
those trials with an intention-to-treat analysis were included, the relative risks of groin 
hematoma and pseudoaneurysm formation were significantly increased (1.89 and 5.40, 
respectively). 
A larger meta-analysis that included 30 studies involving 37,066 patients concluded that the 
risk of complications depended upon the specific device used and whether the procedure 
was a diagnostic catheterization or a PCI [24]. In the overall analysis, there was a significant 
increase in risk with an APCD (odds ratio [OR] 1.34, 95% CI 1.01- 1.79). For reports limited 
to diagnostic studies, there were no significant differences between APCDs and mechanical 
compression, although there were trends toward fewer complications with the AngioSeal 
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device (OR 0.71) and toward more complications with the VasoSeal and Perclose devices 
(OR 1.85 and 1.51, respectively).   
For reports limited to PCI, there were no significant differences between APCDs and 
mechanical compression overall. However, there was a significant increase in vascular 
complications with the VasoSeal device (OR 2.52).   
Closure devices also increase the risk of local infection or endarteritis [25,26]. Although this 
complication is infrequent (0.3 percent in one series) [26], it can be serious when it occurs. 
Consideration should be given to periprocedural antibiotics in immunocompromised 
patients following prolonged arterial access or when sterility has been breached when a 
closure device is used. It may also be prudent for the operator to change gloves prior to 
using an arterial closure device. (See 'Infection' below.) An angiogram of the femoral artery 
should be performed prior to use of an APCD. Use ofclosure devices should be avoided if a 
hematoma has formed during the procedure, or in the presence of severe iliofemoral 
vascular disease, and when the access site is below the bifurcation of the superficial and 
profunda femoral arteries. 
3.1.3 Prior warfarin therapy  
Among patients who are being treated with warfarin, the optimal approach is to withhold 
warfarin and wait until the INR reaches 1.5 before proceeding with catheterization. When 
the procedure cannot be delayed, it has been suggested that, in patients with an INR of 2.0 
to 3.0, manual pressure hemostasis may be sufficient to prevent excess bleeding [27]. In 
patients with an INR >3.0, administration of fresh frozen plasma prior to arterial sheath 
removal may be warranted. The transradial approach may also be useful in such cases. The 
risk of local bleeding in warfarin-treated patients is likely to be greater in those undergoing 
PCI who are often treated with heparin, clopidogrel, and a glycoprotein IIb/IIIa inhibitor. 
These patients typically have longer intraarterial times and more manipulation of the 
arterial access site.increase in risk is seen with severe disease of the left main coronary artery 
(compared to single vessel disease) and with a left ventricular ejection fraction (LVEF) below 
30 percent (compared to an LVEF above 50 percent). 
3.2 Hematoma formation 
Hematoma formation is not uncommon in the soft tissue of the upper thigh and the patient 
should be advised that the development of a large area of ecchymosis is likely. Although 
most resolve over a period of days, femoral nerve compression can occur, which may take 
weeks to months to resolve. Patients should be advised to avoid strenuous activity or lifting 
heavy objects within the first week following arterial catheterization. Surgical repair for a 
hematoma is generally not required. 
3.2.1 Retroperitoneal extension 
If the arterial puncture occurs above the inguinal ligament, hematoma may extend into the 
retroperitoneal space, causing hypotension and ipsilateral flank pain. CT scanning or 
abdominal ultrasonography can help to establish the diagnosis. Treatment is usually 
conservative, consisting of bed rest and blood transfusion rather than surgical correction. 
Reversal of systemic anticoagulation may be indicated if bleeding persists or is associated 
with hemodynamic compromise.  
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3.3 Arteriovenous fistula 
Ongoing bleeding from the arterial puncture site may decompress into the adjacent venous 
puncture site, leading to the formation of an arteriovenous fistula. This complication may be 
recognized by the presence of a thrill or continuous bruit at the site of catheter insertion. 
Surgical repair is usually necessary, since fistulae tend to enlarge over time. The most 
common finding at surgery is a puncture site below the common femoral artery, which 
illustrates the importance of careful technique in avoiding this complication [1].  
3.4 Prior pseudoaneurysm 
If a hematoma remains in continuity with the arterial lumen, a pseudoaneurysm may 
develop with blood flow into and out of the hematoma cavity during systole and diastole. A 
pseudoaneurysm is most often recognized by the presence of a pulsatile mass with a systolic 
bruit over the catheter insertion site; it can be confirmed by duplex ultrasonography. Almost 
all pseudoaneurysms occur within the first three days after removal of the arterial sheath, 
and most of the remaining cases by seven days after sheath removal [28]. 
The main risk factor for pseudoaneurysm formation is an inadequate period of manual 
compression. This was illustrated in a series of 581 angiographic procedures involving 
transfemoral arterial catheterization [29]. A pseudoaneurysm occurred in 14 percent of the 
first 300 procedures in which standard manual compression was performed, compared to 
1.1 percent of the next 281 procedures when manual compression was continued for at least 
five minutes after local bleeding had stopped. 
Other risk factors include large bore sheaths, postprocedural anticoagulation, antiplatelet 
therapy during the intervention, age >65 years, obesity, hypertension, peripheral artery 
disease, hemodialysis, cannulation of the superficial rather than common femoral artery, 
and complex interventions [28-30].  
Surgical management should be performed when a pseudoaneurysm occurs at the site of a 
vascular anastomosis, becomes very large and threatens or causes skin necrosis, is 
expanding rapidly, occurs spontaneously, as it may be infected, or there is a failure of a 
minimally invasive procedure [30]. Expanding hematomas have a propensity towards 
eventual rupture, especially if the patient is maintained on anticoagulation [1,7,31,32].  
Treatment of smaller pseudoaneurysms may be accomplished with either direct ultrasound-
guided compression or with ultrasound-guided local injection of thrombin or collagen into 
the pseudoaneurysm cavity, which has a higher success rate [28,33-35]. Although an 
effective approach, ultrasound-guided compression is uncomfortable for both the patient 
and the person applying compression. 
The success rate of ultrasound-guided injection of bovine thrombin was illustrated in a 
series of 240 patients with simple or complex pseudoaneurysms [28]. The primary success 
rate was 96 percent with simple pseudoaneurysms and 89 percent with complex 
pseudoaneurysms. The secondary success rate was 99.6 percent (all but one patient). The 
authors also reviewed 34 studies with 1388 patients; the overall success rate was 97.2 
percent.  
The high success rate of ultrasound-guided injection has made it the treatment of choice for 
most postcatheterization pseudoaneurysms [30]. However, the procedure should not be 
performed when, as defined above, there is an indication for surgical management. 
In rare cases, pseudoaneurysms less than 2 cm can be managed conservatively and 
monitored by serial imaging to confirm spontaneous resolution.  
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3.5 Arterial thrombosis 
Arterial thrombosis is rare and occurs slightly more often when the brachial approach is 
used [3,4]. Predisposing factors to femoral artery thrombosis include small vessel lumen, 
peripheral artery disease, diabetes mellitus, female sex, placement of a large diameter 
catheter or sheath (eg, intraaortic balloon pump), or a long catheter dwell time [2-7,31,32]. 
Patients with lower extremity pain or paresthesia, plus reduced or absent distal pulses not 
responding to catheter removal, should be evaluated for possible flow obstructing thrombus 
or dissection. Urgent vascular surgery or thrombectomy may be required for preservation of 
the limb. 
3.6 Radial artery access 
Local vascular complications appear to occur less frequently with radial artery access. This 
issue was best addressed in a meta-analysis that evaluated 12 randomized trials including 
3224 patients comparing radial with femoral access [36]. The risk of major adverse cardiac 
events was similar for the two approaches. Radial access was associated with a significantly 
lower incidence of access site complications (odds ratio 0.20, 95% CI 0.09-0.42), but a 
significantly higher rate of procedural failure (odds ratio 3.30. 95% CI 1.63-6.71), probably 
due to the specific technical skills required for this method. 
3.6.1 Integrity of the palmar arch 
Radial artery cannulation is associated with a 5 to 19 percent chance of radial artery 
occlusion [37]. This complication is not clinically important in most patients because the 
hand is perfused by both the radial and ulnar arteries with extensive collateral flow between 
the two. However, some patients have incomplete palmar arches, which may diminish 
collateral perfusion, possibly leading to hand ischemia in the presence of radial artery 
occlusion.  
The modified Allen test has traditionally been used to identify patients at increased risk 
from radial artery catheterization. However, many centers now use pulse oximetry and 
plethysmography.  
The modified Allen test, originally developed to evaluate patients with thromboangiitis 
obliterans, assesses the adequacy of collateral blood supply from the ulnar artery to the 
hand via the palmar arches. The test consists of the following steps: 
 The patient's hand is initially held high while the fist is clenched and both radial and 
ulnar arteries are compressed; this allows the blood to drain from the hand. 
 The hand is then lowered and the fist is opened. 
 After pressure is released over the ulnar artery, color should return to the hand within 
six seconds, indicating a patent ulnar artery and an intact superficial palmar arch. The 
test is considered abnormal if 10 seconds or more is required for color to return. 
In two large series of patients undergoing cardiac catheterization, an abnormal Allen test 
result was obtained in 6 and 27 percent [38,39]. The importance of an abnormal test was 
evaluated in a study of 55 patients undergoing coronary angiography, 20 of whom had an 
abnormal test [37]. After 30 minutes of subsequent radial artery occlusion, the patients with 
an abnormal test had significantly reduced blood flow to the thumb and an elevated thumb 
capillary lactate. 
Based upon such observations, radial artery catheterization is usually not performed in 
patients with an abnormal modified Allen test. A possible exception occurs in patients with 
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an excessive estimated risk from a femoral approach (eg, severe peripheral artery disease, 
large abdominal aortic aneurysm, morbid obesity) [37].  
The results of the modified Allen test can be altered by a number of factors, including 
overextension of the wrist, skin tension over the ulnar artery, and operator error. As a result, 
an appreciable number of false positive and false negative results have been reported [38]. 
As an alternative, many centers use a more direct assessment of blood flow to the thumb 
during radial artery occlusion, which can be accomplished with pulse oximetry and 
plethysmography [38,40]. 
The traditional modified Allen test was compared to pulse oximetry and plethysmography 
in a consecutive series of 1010 patients referred for diagnostic cardiac catheterization [38]. 
The modified Allen test was considered abnormal if palmar blanching persisted for ≥10 
seconds after release of ulnar compression. Plethysmography was observed for two minutes 
during radial artery compression. Plethysmography was characterized as follows: 
 A: no change in the amplitude of the pulse tracing during compression 
 B: reduction in amplitude with compression 
 C: loss of pulse tracing with initial compression, but recovery of flow during two 
minutes of compression (signifying development of collateral flow) 
 D: loss of pulse tracing with no recovery 
Patients in categories A, B and C were considered to have a patent ulnopalmar arch, and 
therefore eligible for radial catheterization. 
The modified Allen test was abnormal in significantly more patients than plethysmography 
(6.3 versus 1.5 percent). The authors concluded that plethysmography more accurately 
demonstrates the adequacy of the ulnopalmar arch, and that the modified Allen test may 
unnecessarily exclude some patients from radial artery catheterization. However, the 
number of patients who underwent radial artery catheterization was not reported, and the 
value of either test for predicting ischemic complications following radial artery 
catheterization was not assessed. 
4. Arrhythmias 
A variety of arrhythmias and conduction disturbances can occur during catheterization. The 
most common, ventricular premature beats, may be induced by catheter introduction into 
the right or left ventricle, and are generally without clinical importance or impact. 
4.1 Ventricular tachycardia or fibrillation 
Ventricular tachycardia or fibrillation is rare complications of catheterization, occurring in 
0.4 percent of cases in the second registry of the Society for Cardiac Angiography [2]. These 
arrhythmias may result from excess catheter manipulation or, more commonly, from 
intracoronary contrast injection. This complication occurs more commonly when ionic and 
hyperosmolar contrast agents are used. 
4.2 Atrial arrhythmias 
Atrial arrhythmias can be induced by cardiac catheterization, especially in response to 
catheter placement into or out of the right atrium during right heart catheterization. These 
arrhythmias usually do not require immediate treatment unless they produce ischemia or 
hemodynamic instability.  
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Atrial flutter is generally well tolerated and can be treated with burst atrial pacing, or 
electrical or pharmacologic cardioversion. Atrial fibrillation, on the other hand, can cause 
clinical sequelae in the setting of a rapid ventricular response or if the loss of atrial systole 
results in hypotension, as in a patient with mitral stenosis or diastolic ventricular 
dysfunction. Synchronized cardioversion should be performed immediately in patients who 
are hemodynamically unstable.  
4.3 Bradycardia 
Bradycardia commonly occurs during coronary angiography, most often at the end of the 
injection of ionic contrast into the right coronary artery. Forceful coughing helps to clear the 
contrast, support perfusion, and restore normal cardiac rhythmtachycardia or fibrillation is 
rare complications of catheterization, occurring in 0.4 percent of cases in the second registry of 
the Society for Cardiac Angiography [2]. These arrhythmias may result from excess catheter 
manipulation or, more commonly, from intracoronary contrast injection. This complication 
occurs more commonly when ionic and hyperosmolar contrast agents are used. 
Vasovagal reactions, which can include bradycardia, hypotension, yawning, and/or sweating, 
are seen in up to 3 percent of patients, particularly if they have pain or are anxious [2]. These 
reactions may occur with palpation or compression of the artery prior to needle access. 
Treatment usually consists of volume administration, atropine (0.5 to 1.0 mg intravenously), 
and removal of the painful stimulus. Patients with critical coronary or valvular disease may 
undergo irreversible decompensation from vagally-mediated hypotension. As a result, rapid 
reversal of hypotension is crucial in this setting.  
4.4 Conduction disturbances 
Conduction disturbances are a rare cause of bradycardia in the catheterization laboratory. 
Patients with pre-existing left bundle branch block may develop asystole with right heart 
catheterization. Patients with pre-existing right bundle branch block may develop asystole 
during left heart catheterization. Atropine is rarely helpful in patients who develop 
complete heart block, but its administration is still recommended. Coughing may help 
support the circulation while the right heart catheter is exchanged for a temporary pacing 
wire. Prophylactic placement of a temporary pacemaker is not necessary, even in patients 
with bundle branch block or intervention in the right coronary artery.  
Frank asystole is rare and there is generally sufficient time for insertion of a pacing wire 
through   a venous sheath [41]. 
5. Perforation of the heart or great vessels 
Perforation is an extremely rare complication of cardiac catheterization. Higher risk 
procedures are those that involve stiffer catheters, including transseptal catheterization, 
endomyocardial biopsy, balloon valvuloplasty, needle pericardiocentesis, and placement of 
a pacing catheter. Older adult women appear to be at particular risk. 
Cardiac perforation is generally heralded by bradycardia and hypotension due to vagal 
stimulation induced by blood in the pericardium. If the patient is hemodynamically stable, 
echocardiography is suggested to document the presence of blood in the pericardial space. 
However, emergent pericardiocentesis should be performed via the subxiphoid approach in 
the presence of hemodynamic instability. 
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Since pericardiocentesis is itself associated with complications, it is best performed under 
echocardiographic guidance or with pressure monitoring. In a study of 91 cases of acute 
tamponade during catheterization, pericardiocentesis was the only therapy necessary in 82 
percent [42]. 
Reversal of anticoagulation may cause blood in the pericardial space to "gel." As a result, we 
generally try to aspirate the majority of the blood in the pericardial space prior to the 
administration of protamine [1]. 
6. Allergic reactions  
Allergic reactions during catheterization may be precipitated by three agents: the local 
anesthetic, the contrast agent, or protamine sulfate.  
6.1 Local anesthetic 
In patients claiming previous reaction to a local anesthetic, the use of a preservative-free 
agent (such as bupivacaine or mepivacaine) may be a safe alternative [1]. 
6.2 Iodinated contrast agents 
Reaction to the contrast agent occurs in up to 1 percent of patients [2-7]. The risk of such a 
reaction is highest in patients with a history of prior contrast reactions. Other conditions, 
such as asthma and other atopic diseases, also confer some risk.  
There are several steps that can reduce the incidence of a reaction in a high-risk patient: 
 Premedication with corticosteroids and H1 antihistamines can reduce the incidence of a 
severe reaction (eg, bronchospasm or shock) to below 1 percent (table 4). 
 The patient should receive a nonionic contrast agent. The incidence of crossreactivity in 
patients who have had previous reactions to older agents is low, although all patients 
with previous reactions should be premedicated [1]. In the past, nonionic contrast 
agents were used selectively, given their higher cost.  
 
Prednisone 50 mg orally 13,7, and 1 h prior to procedure
[In children: 0.5 to 0.7 mg/kg orally, up to 50 mg]
Diphenhydramine 50 mg PO/IM/ or IV 1 h prior to procedure
[In children: 1.25 mg/kg orally, up to 50 mg]
Lower / iso-osmolar RCM should be recommended
Emergency therapy should be available
Table 4. Pretreatment for patients with previous adverse reactions to RCM 
However, the cost of nonionic contrast has fallen significantly. Thus, we recommend using 
nonionic contrast in all patients undergoing coronary angiography. 
If a severe reaction does occur, it should be treated in the same manner as anaphylaxis, and 
can be sometimes be reversed by using boluses of intravenous epinephrine (1:10,000 
epinephrine so that 1 mL = 0.1 mg). One mL of this solution should be administered 
approximately every minute until the arterial pressure is restored.  
However, the rapidity of dosing must be adjusted by the degree of hypotension and the 
level of assessed hypoperfusion. It is rare for a patient to require a total dose of more than 
1.0 mg (10 mL). 








Allergic reactions to protamine sulfate occur occasionally, more often in insulin-dependent 
diabetic patients who have received NPH insulin (which contains protamine) in the past [1]. 
The rapid administration of protamine sulfate can also provoke back pain of unknown 
etiology. 
In current practice, protamine is rarely administered. Most diagnostic catheterizations are 
done without heparin anticoagulation and in most interventional procedures the heparin is 
either allowed to wear off over the next two to three hours prior to sheath removal, or the 
sheath is removed in the fully anticoagulated state using an arterial closure device. 
7. Atheroembolism  
During the process of cardiac catheterization, atheromatous debris is often scraped from the 
aortic wall. This debris can cause systemic embolization, including cutaneous, renal, retinal, 
cerebral, and gastrointestinal emboli (photo 1 and photo 2 and photo 3). To minimize the 
risk of stroke or visual impairment, arterial catheter exchanges are best performed over a 
wire in the descending aorta at the level of the diaphragm (for closed loop catheters) and in 
the ascending aorta for angiographic catheters. Once arterial access has been obtained, the 
practice of readvancing the guidewire through the infrarenal aorta rather than exchanging it 
through a catheter should be avoided. 
 
 
Blue toes are a classic manifestation of peripheral embolization of atheromatous material from proximal 
arterial sources (eg, aorta); the pedal pulses are often normal. This patient, who has a 30-year history of 
type 1 diabetes and severe peripheral vascular disease, presented with foot pain and discoloration. 
Cholesterol microemboli from the aorta were suspected to be the cause.  
Photo 1. Blue toe syndrome 
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The high rate of release of atheromatous debris was illustrated in a series of 1000 patients 
undergoing percutaneous coronary intervention: 51 percent had aortic atheromatous 
material retrieved from the catheter after back flow of blood [43]. There were no associated 
in-hospital ischemic complications, probably due to sufficient withdrawal of blood 
containing the debris prior to the injection of contrast. 
The reported incidence of atheroembolic events varies from 0.6 to 0.9 percent in 
retrospective studies to 1.4 to 1.9 percent in prospective series [44].  
 
 
Patient with lupus and anti-phospholipid antibodies with livedo reticularis (manifested by a reddish-
cyanotic, reticular pattern of the skin) which has resulted in ulcer formation (arrows).  
Photo 2. Livedo reticularis 
The clinical features of atheroembolism after diagnostic cardiac catheterization were 
examined in a prospective evaluation of 1786 patients ≥40 years of age [45]. The following 
observations were made:  
 25 patients (1.4 percent) were diagnosed with atheroembolism; 12 had cutaneous signs 
(eg, "blue toes" syndrome, livedo reticularis) (photo 1 and photo 2) and 16 had acute 
renal failure that was considered to be atheroembolic in origin because it persisted for 
at least two weeks (while contrast nephropathy typically reverses within the first week).  
 Eosinophil counts were significantly higher in patients suffering from atheroembolism 
both before and after catheterization. 
 Four patients with atheroembolism died in hospital (16 percent); all had progressive 








Photo 3. Hollenhorst plaque (cholesterol crystal, arrow) in retinal artery 
8. Acute renal failure  
There are three major causes of renal dysfunction related to cardiac catheterization: contrast-
induced acute renal failure, renal atheroemboli, and hemodynamic instability with renal 
hypoperfusion.  
8.1 Contrast nephropathy  
At least 5 percent of patients who undergo cardiac catheterization experience a transient rise 
in the plasma creatinine concentration of more than 1.0 mg/dL (88 micromol/L) due to 
contrast-induced renal dysfunction [46]. 
However, there is substantial variability in risk among patients, some of whom have a risk 
that exceeds 50 percent. The risk is greatest in patients with moderate to severe renal 
insufficiency and diabetes. 
The plasma creatinine concentration usually returns to baseline within seven days, and less 
than 1 percent of patients, usually diabetic patients with underlying severe chronic kidney 
disease, go on to require chronic hemodialysis.  
Nonionic low osmolal contrast agents are now administered for the majority of radiologic 
procedures using intravascular contrast media, as a result of increased patient tolerability and 
decreased hypersensitivity reactions. However, in patients at risk for contrast nephropathy, we 
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prefer the use of iso-osmolal agents (approximately 290 mosmol/kg) rather than low osmolal 
agents (500 to 850 mosmol/kg) because of a lower risk of contrast nephropathy.  
The 2007 focused update of the ACC/AHA/SCAI 2005 PCI guidelines recommended the use 
of iso-osmolal in preference to low osmolal agents in patients with chronic kidney disease [47]. 
8.2 Renal atheroemboli  
The kidney is one of the principal end organs that may be affected by atheroembolic events. 
(See 'Atheroembolism' above.) There are three main findings that suggest that atheroemboli 
rather than contrast nephropathy is responsible for the development of acute renal failure 
after catheterization:    
 The presence of other signs of embolization such as blue toes (photo 1), livedo reticularis 
(photo 2), Hollenhorst plaques in the retina (photo 3), and/or abdominal pain. 
 Transient eosinophilia and hypocomplementemia. 
 Persistent renal failure after seven days. 
In a review of 1786 consecutive patients undergoing cardiac catheterization, acute renal 
failure developed in 0.9 percent overall and in 64 percent of those with evidence of any 
atheroembolism [45]. In this report, acute renal failure was considered to be due to renal 
atheroembolism if it had persisted for at least two weeks, well beyond the time at which 
contrast nephropathy should have resolved. 
9. Infection  
Cardiac catheterization procedures are performed using sterile technique. Thus, both local 
infection and bacteremia are rare and endocarditis prophylaxis during cardiac 
catheterization is not recommended for patients with valvular disease. Infection is 
approximately 10 times more common with the brachial approach compared to the femoral 
approach (0.6 versus 0.06 percent) [2-7]. 
Infection control guidelines for the cardiac catheterization laboratory were updated in 2006 
by the Society for Cardiovascular Angiography and Interventions [48]. These guidelines 
emphasize the importance of handwashing caps, gowns, gloves, and masks to protect the 
patient against bacterial infection, and measures such as eye wear and vaccination for 
hepatitis B to protect laboratory personnel. 
10. Radiation exposure  
Patients undergoing diagnostic and interventional cardiac catheterization receive substantial 
radiation exposure.  
11. Endomyocardial biopsy 
Endomyocardial biopsy of right ventricular tissue is made using a relatively stiff catheter. 
Complications such as perforation of the heart or great vessels, life threatening arrhythmias, 
or heart block requiring permanent pacing occur uncommonly.  
12. Conclusions 
Cardiac catheterization is a common proceduce with very low incidence of complications 
nowadays. We can consider different kind of adverse events. On the one hand, the events 
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related with the artery access, that are the most common, like haematoma, pseudoaneurysm 
or dissection. On the other hand, we can observe complications more severe like 
embolizations, renal failure or allergic reactions. Death is an uncommon complication, with 
a is generally well below 1 percent.  It is very important to know the potential adverse 
events of these procedures in order to be aware to prevent it as better as possible. 
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